Your browser doesn't support javascript.
loading
A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
Karlson, Björn Wilgot; Zetterstrand, Sofia; Olofsson, Bertil; Elmfeldt, Dag.
Affiliation
  • Karlson BW; AstraZeneca R&D, Mölndal, Sweden. bjorn.w.karlson@astrazeneca.com
Blood Press ; 18(3): 149-56, 2009.
Article in En | MEDLINE | ID: mdl-19462314
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Benzimidazoles / Hydrochlorothiazide / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Female / Humans / Male / Middle aged Language: En Journal: Blood Press Journal subject: ANGIOLOGIA Year: 2009 Document type: Article Affiliation country: Sweden Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Benzimidazoles / Hydrochlorothiazide / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Female / Humans / Male / Middle aged Language: En Journal: Blood Press Journal subject: ANGIOLOGIA Year: 2009 Document type: Article Affiliation country: Sweden Country of publication: United kingdom